Webcast ImageWebcast
Geron 2013 Annual Meeting of Stockholders (Live)
05/22/13 at 2:00 p.m. PT
Geron 2013 Annual Meeting of Stockholders
Wednesday, May 22, 2013 2:00 p.m. PT / 5:00 p.m. ET 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Recent NewsMore >>
DateTitle 
04/25/13Geron Updates Imetelstat Development Strategy, Including Progress of Investigator-Sponsored Study in MyelofibrosisPrinter Friendly Version
04/24/13Geron to Present at the Needham Healthcare ConferencePrinter Friendly Version
04/22/13Geron Announces Conference Call to Discuss First Quarter 2013 Financial ResultsPrinter Friendly Version
Upcoming EventsMore >>
DateTitle
05/22/13
Geron 2013 Annual Meeting of Stockholders
LocationHyatt Regency Burlingame
1333 Bayshore Highway
Burlingame, CA 94010 US
06/13/13
Geron at 18th Congress of European Hematology Association
Stock Information
GERN (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$1.12
Change (%) Stock is Down 0.03 (2.61%)
Volume930,253
Data as of 05/17/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
  
Contact Information

Anna Krassowska, Ph.D.
Tel: 650-473-7765
E-mail: investor@geron.com or media@geron.com



RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close Video
Close Window
Close
Form content here please :)